At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 180 enrolled
Drug / intervention
Placebo Gel +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Comparing the Efficacy and Safety of Clonidine Topical Gel, 0.1% With Placebo in the Management of Pain Associated With Painful Diabetic Neuropathy
In Brief
A Phase 2 clinical trial evaluating Placebo Gel and Clonidine Topical Gel (ARC-4558) for Painful Diabetic Neuropathy. Completed, enrolled 180 participants across 16 sites.
Detailed Summary
The purpose of this study is to determine whether ARC-4558 is effective in managing pain associated with painful diabetic neuropathy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPainful Diabetic Neuropathy
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMay 2008
First PostedJun 2008
Primary CompletionDec 2009
Study CompletionFeb 2010
TodayJul 2026
First PostedJun 12, 2008
Enrollment StartMay 1, 2008
Primary CompletionDec 1, 2009
Study CompletionFeb 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 18.1 years ago
Interventions
Placebo Geldrug
TID x 12 weeks
Clonidine Topical Gel (ARC-4558)drug
TID x 12 weeks